ClinicalThought

Share

Program Content

Activities

  • Emerging HER2 Selective  TKIs
    Emerging HER2-Selective TKIs for HER2-Mutated NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 12, 2024

    Expires: November 11, 2025

Faculty

cover img faculity

Misako Nagasaka, MD, PhD

Associate Clinical Professor
Division of Hematology/Oncology
Department of Medicine
University of California Irvine School of Medicine
Orange, California

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.